156 related articles for article (PubMed ID: 8301984)
21. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
[TBL] [Abstract][Full Text] [Related]
22. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic value of esophageal stimulation. Factors influencing the results in flutter and atrial tachysystole].
Chabert JP; Metz D; Chapoutot L; Doucet J; Laudinat JM; Elaerts J; Blaise C; Bajolet A
Ann Cardiol Angeiol (Paris); 1991 Feb; 40(2):69-74. PubMed ID: 2024915
[TBL] [Abstract][Full Text] [Related]
24. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
[TBL] [Abstract][Full Text] [Related]
25. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
Larsen MT; Lyngborg K; Pedersen F; Corell P
Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
[TBL] [Abstract][Full Text] [Related]
26. Atrial flutter in infants.
Texter KM; Kertesz NJ; Friedman RA; Fenrich AL
J Am Coll Cardiol; 2006 Sep; 48(5):1040-6. PubMed ID: 16949499
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of transesophageal pacing for the interruption of atrial flutter.
Crawford W; Plumb VJ; Epstein AE; Kay GN
Am J Med; 1989 Jun; 86(6 Pt 1):663-7. PubMed ID: 2729317
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
[TBL] [Abstract][Full Text] [Related]
29. [High-frequency electrostimulation of the atrium in therapy of atrial flutter in patients pre-treated with amiodarone].
Suzzi G; Candelpergher G; Buchberger R; Simoncello P; Cernetti C
G Ital Cardiol; 1982; 12(10):702-5. PubMed ID: 7182208
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter.
Niebauer MJ; Brewer JE; Chung MK; Tchou PJ
Am J Cardiol; 2004 Jun; 93(12):1495-9. PubMed ID: 15194019
[TBL] [Abstract][Full Text] [Related]
31. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
[TBL] [Abstract][Full Text] [Related]
32. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
[TBL] [Abstract][Full Text] [Related]
33. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
34. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
35. [Echocardiographic factors predicting the maintenance of sinus rhythm one year after cardioversion for non-valvular atrial arrhythmias].
Pérez Y; Duval AM; Carville C; Wéber H; Cachin JC; Castaigne A; Guéret P
Arch Mal Coeur Vaiss; 1997 Jul; 90(7):911-8. PubMed ID: 9339251
[TBL] [Abstract][Full Text] [Related]
36. [Atrial flutter yesterday and today].
Disertori M; Vergara G; Inama G; Guarnerio M; Furlanello F
G Ital Cardiol; 1985 Oct; 15(10):985-91. PubMed ID: 3912255
[No Abstract] [Full Text] [Related]
37. [Atrial flutter--diagnosis and therapeutic possibilities].
Chen J; Ohm OJ; Hoff PI; Rossvoll O; Erga KS; Faerestrand S
Tidsskr Nor Laegeforen; 2001 Mar; 121(8):931-4. PubMed ID: 11332381
[TBL] [Abstract][Full Text] [Related]
38. Type II atrial flutter interruption with transesophageal pacing: use of propafenone and possible change of the substrate.
Doni F; Staffiere E; Manfredi M; Piemonti C; Todd S; Rimondini A; Fiorentini C
Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1958-61. PubMed ID: 8945077
[TBL] [Abstract][Full Text] [Related]
39. Transesophageal pacemaker therapy in atrial flutter after procainamide pretreatment.
Rostás L; Antal K; Putorek Z
Am J Ther; 1999 Sep; 6(5):237-40. PubMed ID: 11329104
[TBL] [Abstract][Full Text] [Related]
40. Neonatal intractable atrial flutter successfully treated with intravenous flecainide.
Suzumura H; Nitta A; Ono M; Arisaka O
Pediatr Cardiol; 2004; 25(2):154-6. PubMed ID: 14681740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
